AKBA Operating Cash Flow Growth
Akebia Therapeutics Inc · Operating Cash Flow Growth
AKBA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported1829.17%period ending
AKBA TTM Cash from Operations YoY % (-176.16% → 1829.17%)
Year-over-year change
High-resolution chart · PNG
AKBA operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 1,829.1719% | |
| 273.413% | |
| 267.225% | |
| 184.1459% | |
| 93.8342% | |
| -37.7245% | |
| -73.8753% | |
| 49.177% | |
| -12.0461% | |
| 63.4034% | |
| 68.0346% | |
| 6.8009% | |
| 79.7016% | |
| 66.1144% | |
| 71.0814% | |
| 63.2102% | |
| 10.7073% | |
| -122.6654% | |
| -129.1599% | |
| -28.6466% | |
| -43.7337% | |
| 56.2197% | |
| 57.121% | |
| 28.1433% | |
| 49.1284% | |
| 2.7858% | |
| -164.0583% | |
| -494.9394% | |
| -218.788% | |
| -221.2213% | |
| -73.6035% | |
| -171.88% | |
| -200.0802% | |
| -316.3941% | |
| -196.983% | |
| 192.1106% | |
| 298.3962% | |
| 216.2172% | |
| 210.4929% | |
| -56.7936% | |
| -17.5619% | |
| 10.7179% | |
| -90.6888% | |
| -66.8904% | |
| -71.8616% | |
| -88.6324% | |
| -142.5326% | |
| -176.1607% |